Search Results for "Gene Therapy For Erectile Dysfunction Rats"
Matching Channels
Erectile dysfunction (ED or impotence) is the inability to get and maintain an erection that is sufficient for satisfactory sexual intercourse, and affects half of all men between the ages of 40 to...
p53 Gene Therapy rDNA Introgen
Matching News
[Seminar] Erectile dysfunction
Erectile dysfunction is a common clinical entity that affects mainly men older than 40 years. In addition to the classical causes of erectile dysfunction, such as diabetes mellitus and hypertension, s...
TCT: Stents Help Some Erectile Dysfunction (CME/CE)
MIAMI (MedPage Today) -- Stenting blocked arteries in the pelvis may improve sexual function for certain men with erectile dysfunction unresponsive to medical therapy, longer-term follow-up of a pilot...
Losartan Improves Erectile Dysfunction in Diabetic Patients
Is losartan alone effective in treating erectile dysfunction in diabetics -- or is combination therapy with tadalafil more beneficial? International Journal of Impotence Research
Erectile dysfunction may increase a man's heart woes
By Rachael RettnerMyHealthNewsDailyThe more severe a man's erectile dysfunction is, the greater his risk of being hospitalized for heart problems, a new Australian study finds. Among men in the study...
Testosterone replacement added to sildenafil therapy is no better than sildenafil plus placebo at improving erectile function in men with erectile dysfunction (ED) and low testosterone. read more
Opioids Tied to Low T, Erectile Dysfunction? (CME/CE)
(MedPage Today) -- Opioid use, particularly long-term use, may be associated with erectile dysfunction and low testosterone, researchers found.
Erectile Dysfunction Stent Restenosis Rate Disappointing
One third of the stents used to treat erectile dysfunction were partially occluded after a year, investigators say. Medscape Medical News
Matching PubMed Articles
Evaluation of vitamin E in the treatment of erectile dysfunction in aged rats.
The present study aims to elucidate the role of oxidative stress in erectile dysfunction associated with aging and to investigate the effect of treatment with vitamin E in this respect.
Gene Therapy for Erectile Dysfunction: What Is the Future?
Gene transfer for the treatment of erectile dysfunction has completed phase 1 safety testing and has shown the necessary safety to proceed to the next level of clinical trial. This review focuses on t...
Erectile dysfunction may affect 30% to 50% of men aged 40 to 70 years, with age, smoking, and obesity being the main risk factors, although 20% of cases have psychological causes. METHODS AND OUTCOMES...
Vascular endothelial growth factor (VEGF) is a cytokine involved in angiogenesis and is closely related to the nitric oxide-cyclic guanosine monophosphate pathway, a target for sildenafil. We investig...
Lifestyle/Dietary recommendations for erectile dysfunction and female sexual dysfunction.
Sexual problems are diffuse in both genders. Although epidemiologic evidence seems to support a role for lifestyle factors in erectile dysfunction, limited data are available suggesting the treatment...